University systems team up to advance research
Houston – Governor Rick Perry joined Texas A&M University System Chancellor Michael D. McKinney, M.D., and University of Texas System Chancellor Francisco G. Cigarroa, M.D., Wednesday to announce a major cancer research initiative between the institutions.
The new collaboration will combine the resources of the A&M System's National Center for Therapeutic Manufacturing and UT's MD Anderson Cancer Center to develop new cancer-fighting drugs and accelerate the process of getting new cancer treatments to patients.
The NCTM is the state of Texas' core biological pharmaceutical manufacturing, research and education facility, now in construction on the Texas A&M University campus. Once complete, researchers from both university systems will utilize the NCTM's first-in-class resources to produce vaccines and therapies for clinical use in the fight against cancer.
Through this agreement, MD Anderson will become a long-term partner and collaborator of the NCTM, increasing the ability of researchers from its laboratories to quickly provide important new cancer vaccines and treatments, including vaccines targeted to specific individuals.